首页> 美国卫生研究院文献>other >Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era
【2h】

Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era

机译:在现代治疗时代乳房切除术后放射疗法在腋窝淋巴结有1-3个阳性肿瘤且≤5cm的乳腺癌中的应用趋势

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite high-level evidence, the benefit of postmastectomy RT in these patients in recent years has not been fully elucidated. We investigated postmastectomy radiotherapy (RT) use and evaluated clinicopathologic and treatment factors influencing RT use in Korean women with pT1-2N1 breast cancer.We identified women diagnosed with pT1-2N1 breast cancer between 1994 and 2009 using the Korean Breast Cancer Registry. Factors associated with RT use were evaluated using logistic regression analysis. The median follow-up was 95 months.Of the 6196 women, 11.9% underwent postmastectomy RT. RT was applied more frequently in women with 3 positive lymph nodes (adjusted odds ratio [OR], 2.69) and larger tumors (OR per centimeter, 1.10). RT use was not significantly associated with well-established risk factors (e.g., tumor grade, hormone receptor status, and lymphovascular space invasion). Although RT utilization increased gradually during the study period (OR per year, 1.07), factors associated with RT were similar over time. The estimated 5-year overall survival increased significantly from 84.1% in 1994 to 2000 to 94.6% in 2005 to 2009.This population-based analysis revealed that the indications for postmastectomy RT in pT1-2N1 breast cancer in Korea are based solely on conventional anatomical factors, although their survival has increased significantly in the modern treatment era. There is a significant unmet need for better risk stratification in these patients and for tailored RT with the incorporation of tumor biology-associated factors.
机译:尽管有大量证据表明,近年来仍未完全阐明乳房切除术后放疗对这些患者的益处。我们调查了乳房切除术后放疗(RT)的使用,并评估了影响pT1-2N1乳腺癌的韩国女性使用RT的临床病理和治疗因素.1994年至2009年间,我们通过韩国乳腺癌登记系统确定了诊断为pT1-2N1乳腺癌的女性。使用逻辑回归分析评估与RT使用相关的因素。中位随访时间为95个月。在6196名妇女中,有11.9%接受了乳房切除术后放疗。在3个阳性淋巴结(比值比[OR]为2.69)和较大肿瘤(OR /厘米为1.10)的女性中,RT的使用频率更高。使用RT与确定的危险因素(例如肿瘤等级,激素受体状态和淋巴血管空间浸润)没有显着相关性。尽管在研究期间RT利用率逐渐提高(每年OR,1.07),但与RT相关的因素随着时间的推移相似。估计的5年总生存率从1994年的2000年的84.1%显着提高到2005年的2009年的94.6%。这项基于人群的分析显示,韩国pT1-2N1乳腺癌的乳房切除术后放疗指征完全基于常规解剖学尽管在现代治疗时代,它们的生存率已显着提高,但仍然存在许多因素。对于这些患者中更好的风险分层以及结合肿瘤生物学相关因素进行定制RT的需求尚未得到满足。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号